Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: Americans keep poisoning themselves | Device recalled over safety concerns | ACC takes on antiplatelet therapies
Saturday, July 4, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Americans keep poisoning themselves with semaglutide, other weight loss drugs

These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021. 

READ MORE >
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Americans keep poisoning themselves with semaglutide, other weight loss drugs

Share on Twitter Share on Facebook Share on Linkedin
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021. 
READ MORE >

Parents charged with murder after 7-year-old son died of heart disease at 255 pounds

The young boy was allegedly living on a diet of potato chips and other unhealthy snacks. One prosecutor described the case as "extraordinary, terrible neglect."  

READ MORE >
handcuffs arrested arrest jail
Share on Twitter Share on Facebook Share on Linkedin

Parents charged with murder after 7-year-old son died of heart disease at 255 pounds

Share on Twitter Share on Facebook Share on Linkedin
handcuffs arrested arrest jail
The young boy was allegedly living on a diet of potato chips and other unhealthy snacks. One prosecutor described the case as "extraordinary, terrible neglect."  
READ MORE >

Neurovascular device recalled due to safety concerns

The recall includes a total of nearly 45,000 devices that should be returned to the manufacturer.

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

Neurovascular device recalled due to safety concerns

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The recall includes a total of nearly 45,000 devices that should be returned to the manufacturer.
READ MORE >

ACC guidance explores antiplatelet therapies for the management of ASCVD

When should heart patients be taking daily aspirin? That's just one of the many questions explored in a new scientific statement.

READ MORE >
Based on this evidence, its is recommended using monotherapy with ticagrelor or prasugrel after one to three months of DAPT after PCI for acute coronary syndrome (ACS), but not using monotherapy of aspirin or clopidogrel unless the patient has a high bleeding risk.
Share on Twitter Share on Facebook Share on Linkedin

ACC guidance explores antiplatelet therapies for the management of ASCVD

Share on Twitter Share on Facebook Share on Linkedin
Based on this evidence, its is recommended using monotherapy with ticagrelor or prasugrel after one to three months of DAPT after PCI for acute coronary syndrome (ACS), but not using monotherapy of aspirin or clopidogrel unless the patient has a high bleeding risk.
When should heart patients be taking daily aspirin? That's just one of the many questions explored in a new scientific statement.
READ MORE >

Cardiologist compensation keeps rising—but are we nearing a tipping point?

Many cardiologists are earning more in 2026 than they did in 2025. However, there is a fear that compensation and wRVUs can only climb so far in this current healthcare environment before things start to stall. 

READ MORE >
physician money payments dollars
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist compensation keeps rising—but are we nearing a tipping point?

Share on Twitter Share on Facebook Share on Linkedin
physician money payments dollars
Many cardiologists are earning more in 2026 than they did in 2025. However, there is a fear that compensation and wRVUs can only climb so far in this current healthcare environment before things start to stall. 
READ MORE >

Medline recalls procedure kits due to catheter safety concerns

Thousands of procedure kits used by cardiologists and cardiac surgeons are impacted by the new Class II recall. 

READ MORE >
warning safety alert recall healthcare issue
Share on Twitter Share on Facebook Share on Linkedin

Medline recalls procedure kits due to catheter safety concerns

Share on Twitter Share on Facebook Share on Linkedin
warning safety alert recall healthcare issue
Thousands of procedure kits used by cardiologists and cardiac surgeons are impacted by the new Class II recall. 
READ MORE >

Heart failure drug recalled due to risk of contamination

The Class II recall includes nearly 935,000 bottles of a medication that has been on the market for years. 

READ MORE >
FDA Recall
Share on Twitter Share on Facebook Share on Linkedin

Heart failure drug recalled due to risk of contamination

Share on Twitter Share on Facebook Share on Linkedin
FDA Recall
The Class II recall includes nearly 935,000 bottles of a medication that has been on the market for years. 
READ MORE >

New York cardiologist performs first procedure in US with FDA-cleared imaging tech

The OpusWave Dual Sensor Imaging System captures both IVUS and OFDI, providing users with two complementary views of the coronaries at the same time.

READ MORE >
Terumo OpusWave
Share on Twitter Share on Facebook Share on Linkedin

New York cardiologist performs first procedure in US with FDA-cleared imaging tech

Share on Twitter Share on Facebook Share on Linkedin
Terumo OpusWave
The OpusWave Dual Sensor Imaging System captures both IVUS and OFDI, providing users with two complementary views of the coronaries at the same time.
READ MORE >

AI is transforming cardiac imaging—often in ways clinicians do not recognize

AI impacts care in so many ways now that it often goes unnoticed by clinicians. 

READ MORE >
Damini Dey, PhD, FSCCT, a professor of biomedical sciences, co-associate director of the Biomedical Imaging Research Institute, and director of the quantitative image analysis program at Cedars-Sinai, explains how artificial intelligence (AI) is impacting cardiovascular imaging without most people realizing.
Share on Twitter Share on Facebook Share on Linkedin

AI is transforming cardiac imaging—often in ways clinicians do not recognize

Share on Twitter Share on Facebook Share on Linkedin
Damini Dey, PhD, FSCCT, a professor of biomedical sciences, co-associate director of the Biomedical Imaging Research Institute, and director of the quantitative image analysis program at Cedars-Sinai, explains how artificial intelligence (AI) is impacting cardiovascular imaging without most people realizing.
AI impacts care in so many ways now that it often goes unnoticed by clinicians. 
READ MORE >

Cardiology groups around the world unite to redefine heart failure

The groups hope to standardize heart failure terminology and ensure everyone is on the same page when discussing this complex condition. 

READ MORE >
Illustration of cardiologists going through the certification process. American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
Share on Twitter Share on Facebook Share on Linkedin

Cardiology groups around the world unite to redefine heart failure

Share on Twitter Share on Facebook Share on Linkedin
Illustration of cardiologists going through the certification process. American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
The groups hope to standardize heart failure terminology and ensure everyone is on the same page when discussing this complex condition. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: TAVR vs. SAVR | FDA clears AI tech | Payment model confusion | Private equity & cardiology | Injuries after PCI
Heart surgery kits recalled | Sex-specific outcomes after TAVR & SAVR | A new risk calculator | FDA clears tricuspid valve
Thousands of heart surgery kits recalled | TAVR for AR linked to 'encouraging' data | Carotid IVL | Progress for new HCM drug
AI company founded by cardiologist makes big splash | Getting clinicians on the same page | Kidney injuries after PCI
Sweeping TAVR changes on the way | Pushing back against AI-powered prior authorization | FDA highlights recall after injuries
Cardiologists added to payment model by mistake | Sex-specific outcomes after TAVR & SAVR | FDA clears new AI software
Private equity unlikely to dominate cardiology | Cardiology opposes Medicare AI prior authorization | New AATS leaders

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Current page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup